Send us Feedback

ViroPharma (VPHM)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

VPHM » Topics » SIGNATURES

This excerpt taken from the VPHM 8-K filed Oct 28, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIROPHARMA INCORPORATED

Date: October 28, 2009

   By:  

/S/    J. Peter Wolf    

   

J. Peter Wolf

Vice President, General Counsel and Secretary

This excerpt taken from the VPHM 8-K filed Oct 23, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    VIROPHARMA INCORPORATED
Date: October 23, 2009     By:  

/S/    J. PETER WOLF        

      J. Peter Wolf
      Vice President, General Counsel and Secretary
This excerpt taken from the VPHM 8-K filed Aug 5, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIROPHARMA INCORPORATED
Date: August 4, 2009   By:  

/s/ J. Peter Wolf

    J. Peter Wolf
    Vice President, General Counsel and Secretary

This excerpt taken from the VPHM 8-K filed Aug 5, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIROPHARMA INCORPORATED
   

Date: August 4, 2009

  

By:

   /s/ J. Peter Wolf
   

J. Peter Wolf

Vice President, General Counsel and Secretary

 

This excerpt taken from the VPHM 8-K filed Jul 29, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    VIROPHARMA INCORPORATED

Date: July 29, 2009

     By:  

/s/    J. Peter Wolf        

      J. Peter Wolf
      Vice President, General Counsel and Secretary

This excerpt taken from the VPHM 8-K filed Jul 15, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIROPHARMA INCORPORATED
Date: July 15, 2009   By:  

/s/ J. Peter Wolf

    J. Peter Wolf
    Vice President, General Counsel and Secretary
This excerpt taken from the VPHM 8-K filed Jun 23, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIROPHARMA INCORPORATED
Date: June 23, 2009   By:  

/s/ J. Peter Wolf

    J. Peter Wolf
    Vice President, General Counsel and Secretary
This excerpt taken from the VPHM 8-K filed Jun 17, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIROPHARMA INCORPORATED
Date: June 17, 2009   By:  

/s/ J. Peter Wolf

    J. Peter Wolf
    Vice President, General Counsel and Secretary
This excerpt taken from the VPHM 8-K filed Jun 8, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIROPHARMA INCORPORATED
Date: June 8, 2009   By:  

/s/ J. Peter Wolf

    J. Peter Wolf
    Vice President, General Counsel and Secretary

This excerpt taken from the VPHM 8-K filed Jun 4, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIROPHARMA INCORPORATED
Date: June 4, 2009   By:  

/s/ J. Peter Wolf

    J. Peter Wolf
    Vice President, General Counsel and Secretary

This excerpt taken from the VPHM 8-K filed May 29, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIROPHARMA INCORPORATED
Date: May 29, 2009   By:  

/s/ J. Peter Wolf

    J. Peter Wolf
    Vice President, General Counsel and Secretary

This excerpt taken from the VPHM 8-K filed May 26, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIROPHARMA INCORPORATED
Date: May 26, 2009   By:  

/s/ J. Peter Wolf

    J. Peter Wolf
    Vice President, General Counsel and Secretary
This excerpt taken from the VPHM 10-Q filed May 4, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  VIROPHARMA INCORPORATED
Date: May 1, 2009   By:  

/s/ Vincent J. Milano

    Vincent J. Milano
    President and Chief Executive Officer
    (Principal Executive Officer)
  By:  

/s/ Charles A. Rowland, Jr.

    Charles A. Rowland, Jr.
    Vice President, Chief Financial Officer
    (Principal Financial Officer)
  By:  

/s/ Richard S. Morris

    Richard S. Morris
    Chief Accounting Officer and Controller
    (Principal Accounting Officer)

 

38

This excerpt taken from the VPHM 8-K filed Apr 29, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    VIROPHARMA INCORPORATED
Date: April 29, 2009   By:  

/s/    J. Peter Wolf

   

J. Peter Wolf

Vice President, General Counsel and Secretary

This excerpt taken from the VPHM 8-K filed Mar 24, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIROPHARMA INCORPORATED
Date: March 24, 2009   By:  

/s/ J. Peter Wolf

    J. Peter Wolf
    Vice President, General Counsel and Secretary

This excerpt taken from the VPHM 8-K filed Mar 18, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIROPHARMA INCORPORATED
Date: March 18, 2009   By:  

/s/ J. Peter Wolf

    J. Peter Wolf
    Vice President, General Counsel and Secretary

This excerpt taken from the VPHM 10-K filed Mar 2, 2009.

SIGNATURES

STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be
signed on our behalf by the undersigned, thereunto duly authorized.

 





















VIROPHARMA INCORPORATED

By: 

/s/ Vincent J. Milano

 

Vincent J. Milano

President, Chief Executive Officer

This excerpt taken from the VPHM 8-K filed Feb 27, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    VIROPHARMA INCORPORATED
Date: February 27, 2009   By:  

/s/    J. Peter Wolf

    J. Peter Wolf
    Vice President, General Counsel and Secretary
This excerpt taken from the VPHM 8-K filed Feb 24, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIROPHARMA INCORPORATED
Date: February 24, 2009   By:  

/s/    J. Peter Wolf

   

J. Peter Wolf

Vice President, General Counsel and Secretary

This excerpt taken from the VPHM 8-K filed Feb 13, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIROPHARMA INCORPORATED
Date: February 13, 2009   By:  

/s/    J. Peter Wolf

    J. Peter Wolf
    Vice President, General Counsel and Secretary

This excerpt taken from the VPHM 8-K filed Feb 9, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    VIROPHARMA INCORPORATED
Date: February 9, 2009   By:  

/s/ J. Peter Wolf

    J. Peter Wolf
    Vice President, General Counsel and Secretary

This excerpt taken from the VPHM 8-K filed Feb 3, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIROPHARMA INCORPORATED
Date: February 3, 2009   By:  

/s/ J. Peter Wolf

    J. Peter Wolf
    Vice President, General Counsel and Secretary

This excerpt taken from the VPHM 8-K filed Jan 14, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIROPHARMA INCORPORATED
Date: January 14, 2009   By:  

/s/ J. Peter Wolf

    J. Peter Wolf
    Vice President, General Counsel and Secretary

This excerpt taken from the VPHM 8-K filed Dec 23, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIROPHARMA INCORPORATED

Date: December 22, 2008

   By:  

/s/ J. Peter Wolf

    J. Peter Wolf
    Vice President, General Counsel and Secretary

This excerpt taken from the VPHM 8-K filed Dec 18, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

      VIROPHARMA INCORPORATED
Date: December 18, 2008     By:  

/s/    J. Peter Wolf

       

J. Peter Wolf

Vice President, General Counsel and Secretary

This excerpt taken from the VPHM 8-K filed Dec 16, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIROPHARMA INCORPORATED
Date: December 15, 2008   By:  

/s/ J. Peter Wolf

    J. Peter Wolf
    Vice President, General Counsel and Secretary

This excerpt taken from the VPHM 8-K filed Dec 2, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIROPHARMA INCORPORATED
Date: December 1, 2008   By:  

/s/ J. Peter Wolf

    J. Peter Wolf
    Vice President, General Counsel and Secretary

This excerpt taken from the VPHM 8-K filed Nov 14, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereto duly authorized.

 

  VIROPHARMA INCORPORATED
Date: November 14, 2008   By:  

/s/    J. Peter Wolf

  Name:   J. Peter Wolf
  Title:   ViroPharma Incorporated

 

4

This excerpt taken from the VPHM 10-Q filed Oct 29, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    VIROPHARMA INCORPORATED
Date:   October 27, 2008   By:  

/s/ Vincent J. Milano

      Vincent J. Milano
     

President and Chief Executive Officer

(Principal Executive Officer)

    By:  

/s/ Richard S. Morris

      Richard S. Morris
     

Chief Accounting Officer and Controller

(Principal Accounting Officer)

 

40

This excerpt taken from the VPHM 8-K filed Oct 29, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    VIROPHARMA INCORPORATED
Date: October 29, 2008   By:  

/s/ J. Peter Wolf

    J. Peter Wolf
    Vice President, General Counsel and Secretary

This excerpt taken from the VPHM 8-K filed Oct 24, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

   VIROPHARMA INCORPORATED

Date: October 24, 2008

    By:   /s/ J. Peter Wolf
      
     J. Peter Wolf
     Vice President, General Counsel and Secretary

This excerpt taken from the VPHM 8-K filed Oct 21, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIROPHARMA INCORPORATED
Date: October 20, 2008   By:  

/s/ J. Peter Wolf

    J. Peter Wolf
    Vice President, General Counsel and Secretary

This excerpt taken from the VPHM 8-K filed Oct 14, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIROPHARMA INCORPORATED
Date: October 14, 2008   By:  

/s/ J. Peter Wolf

    J. Peter Wolf
    Vice President, General Counsel and Secretary

This excerpt taken from the VPHM 8-K filed Sep 12, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIROPHARMA INCORPORATED
Date: September 10, 2008   By:  

/s/ J. Peter Wolf

    J. Peter Wolf
    Vice President, General Counsel and Secretary
This excerpt taken from the VPHM 8-K filed Sep 3, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIROPHARMA INCORPORATED
Date: September 3, 2008   By:  

/s/ J. Peter Wolf

    J. Peter Wolf
    Vice President, General Counsel and Secretary

This excerpt taken from the VPHM 8-K filed Jul 30, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    VIROPHARMA INCORPORATED
Date: July 30, 2008     By:   /s/ J. Peter Wolf
     

J. Peter Wolf

Vice President, General Counsel and Secretary

This excerpt taken from the VPHM 10-Q filed Jul 30, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    VIROPHARMA INCORPORATED
Date: July 28, 2008   By:  

/s/ Vincent J. Milano

   

Vincent J. Milano

President, Chief Executive Officer, Chief Financial Officer and Treasurer

(Principal Executive Officer)

  By:  

/s/ Richard S. Morris

   

Richard S. Morris

Chief Accounting Officer and Controller

(Principal Accounting Officer)

 

36

This excerpt taken from the VPHM 8-K filed Jul 18, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIROPHARMA INCORPORATED
Date: July 18, 2008   By:  

/s/ J. Peter Wolf

    J. Peter Wolf
    Vice President, General Counsel and Secretary

This excerpt taken from the VPHM 8-K filed Jul 15, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    VIROPHARMA INCORPORATED
Date: July 15, 2008     By:   /s/ J. Peter Wolf
        J. Peter Wolf
        Vice President, General Counsel and Secretary

This excerpt taken from the VPHM 8-K filed May 29, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIROPHARMA INCORPORATED
Date: May 29, 2008   By:  

/s/ J. Peter Wolf

    J. Peter Wolf
    Vice President, General Counsel and Secretary

This excerpt taken from the VPHM 8-K filed May 28, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIROPHARMA INCORPORATED
Date: May 28, 2008   By:  

/s/ J. Peter Wolf

    J. Peter Wolf
    Vice President, General Counsel and Secretary
This excerpt taken from the VPHM 8-K filed May 20, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    VIROPHARMA INCORPORATED
Date: May 20, 2008     By:  

/s/ J. Peter Wolf

      J. Peter Wolf
      Vice President, General Counsel and Secretary
This excerpt taken from the VPHM 8-K filed Apr 30, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIROPHARMA INCORPORATED
Date: April 30, 2008   By:  

/s/ J. Peter Wolf

    J. Peter Wolf
    Vice President, General Counsel and Secretary

EXCERPTS ON THIS PAGE:

8-K
Oct 28, 2009
8-K
Oct 23, 2009
8-K
Aug 5, 2009
8-K
Aug 5, 2009
8-K
Jul 29, 2009
8-K
Jul 15, 2009
8-K
Jun 23, 2009
8-K
Jun 17, 2009
8-K
Jun 8, 2009
8-K
Jun 4, 2009
8-K
May 29, 2009
8-K
May 26, 2009
10-Q
May 4, 2009
8-K
Apr 29, 2009
8-K
Mar 24, 2009
8-K
Mar 18, 2009
10-K
Mar 2, 2009
8-K
Feb 27, 2009
8-K
Feb 24, 2009
8-K
Feb 13, 2009
8-K
Feb 9, 2009
8-K
Feb 3, 2009
8-K
Jan 14, 2009
8-K
Dec 23, 2008
8-K
Dec 18, 2008
8-K
Dec 16, 2008
8-K
Dec 2, 2008
8-K
Nov 14, 2008
10-Q
Oct 29, 2008
8-K
Oct 29, 2008
8-K
Oct 24, 2008
8-K
Oct 21, 2008
8-K
Oct 14, 2008
8-K
Sep 12, 2008
8-K
Sep 3, 2008
8-K
Jul 30, 2008
10-Q
Jul 30, 2008
8-K
Jul 18, 2008
8-K
Jul 15, 2008
8-K
May 29, 2008
8-K
May 28, 2008
8-K
May 20, 2008
8-K
Apr 30, 2008

RELATED TOPICS for VPHM:

"SIGNATURES" elsewhere:

Acorda Therapeutics (ACOR)
AEterna Zentaris (AEZS)
Affymetrix (AFFX)
Alnylam Pharmaceuticals (ALNY)
Amylin Pharmaceuticals (AMLN)
Anika Therapeutics (ANIK)
American Oriental Bioengineering (AOB)
BioMarin Pharmaceutical (BMRN)
Cadence Pharmaceuticals (CADX)
Cambrex (CBM)
Cephalon (CEPH)
Charles River Laboratories International (CRL)
Crucell NV (CRXL)
Dendreon (DNDN)
Dyax (DYAX)
Emergent Biosolutions (EBS)
Enzon Pharmaceuticals (ENZN)
Exelixis (EXEL)
Halozyme Therapeutics (HALO)
Heska (HSKA)
Endo Pharmaceuticals Solutions Inc. (IDEV)
Illumina (ILMN)
Incyte (INCY)
Martek Biosciences (MATK)
Medivation (MDVN)
Medarex (MEDX)
Neurocrine Biosciences (NBIX)
NGEN, INC. (NGEN)
Transcept Pharmaceuticals Inc (NOVC)
NPS Pharmaceuticals (NPSP)
ARCA biopharma, Inc. (NUVO)
Obagi Medical Products (OMPI)
Omrix Biopharmaceuticals (OMRI)
ONYX Pharmaceuticals (ONXX)
Optimer Pharmaceuticals (OPTR)
OSI Pharmaceuticals (OSIP)
PerkinElmer (PKI)
Questcor Pharmaceuticals (QSC)
Regeneron Pharmaceuticals (REGN)
Repligen (RGEN)
Seattle Genetics (SGEN)
Sequenom (SQNM)
3SBio (SSRX)
Tongjitang Chinese Medicines Company (TCM)
Tercica (TRCA)
Targacept (TRGT)
ZymoGenetics (ZGEN)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki